tiprankstipranks

David Novak Profile - Raymond James Analyst

46 Followers
tipranks
David Novak

David Novak
Raymond James

Wall Street Analyst
#8,212 out of 8,741 Wall Street Analysts
#30,016 out of 36,828 experts

Success Rate

25%
17 out of 68 ratings made a profit

Average Return

-11.20%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying David Novak's trades since 2021 and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -11.2% per rating.

Stock Rating Distribution

108Ratings
85.19% Buy
14.81% Hold
0.00% Sell
Distribution of David Novak's ratings

Additional Information

Main Sector:General
Geo Coverage:
CanadaCanadian Market
United StatesUS Market

Best Rating

Stock:
Zymeworks
(ZYME)
Rating:Buy
Date:Nov 27, 2018 - Nov 27, 2019
Return:+257.90%
The most profitable rating made by David Novak

David Novak's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Eupraxia Pharmaceuticals
Apr 13, 2021
Buy
Initiated
C$13.00
(86.51% Upside)
1Ratings
0%
-73.50%
Gyre Therapeutics
Apr 29, 2021
Buy
Reiterated
$19.00
(-13.75% Downside)
9Ratings
0%
-58.48%
Antibe Therapeutics
Aug 04, 2021
Buy
Reiterated
C$4.00
(288.35% Upside)
2Ratings
0%
-64.25%
Leap Therapeutics
Sep 13, 2021
Buy
Reiterated
$4.00
(34.68% Upside)
13Ratings
40%
+2.64%
Alaunos Therapeutics
Nov 09, 2021
Hold
Reiterated
$2.00
(3.63% Upside)
11Ratings
25%
-17.59%
Zymeworks
Dec 09, 2021
Buy
Reiterated
$74.00
(519.77% Upside)
26Ratings
53%
+13.12%
Dec 22, 2021
Hold
Reiterated
$1.30
7Ratings
0%
-13.80%
Biosyent
Mar 10, 2022
Hold
Reiterated
C$8.00
(-5.99% Downside)
14Ratings
25%
+12.90%
Knight Therapeutics
Apr 01, 2022
Buy
Reiterated
C$7.50
(36.12% Upside)
25Ratings
11%
-11.38%
List of latest recommendations made by David Novak. Click to expand and see David Novak's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

David Novak activity FAQ

What is the performance of David Novak's recommendations?
The percentage of profitable recommendations made by David Novak is 25%, and the average return per transaction is -11.20%.
    What stocks does David Novak cover?
    David Novak mostly covers ZYME , TSE:GUD , TSE:RX stocks.
      What was David Novak’s latest rating?
      David Novak latest rating was a buy on GYRE with a price target of $19.00, which represents an Downside of -13.75%
        What was David Novak's most profitable rating?
        David Novak’s most profitable ratings was a buy on ZYME stock on Nov 27, 2018 - Nov 27, 2019. The return on the trade was +257.90%.
          Where can I see a list of stock analyst ratings?
          You can see a list of daily stock analyst ratings here.
            What are the most recommended stocks by analysts?
            You can see a list of the most recommended stocks by analysts here